Abstract

Increasing report of persistent and disabling symptoms after recovery from acute COVID -19 have been reported and that have termed as “ Long COVID “ and it occur in 10% to 30% of cases . On neurological point of view patients describe memory impairment abs concentration , described as “ brain fog “ and is highly suggestive of chronic fatigue syndrome. Although a specific treatment is not yet validated to treat Long COVID syndrome , we reported our experience with ivermectin in such patients. We treated 50 patients with 0,2 mg /kg to 0,4 mg/kg for 3 to 7 days according symptomatic expression ( mild to moderate ). We found a resolution in 85% of the patients treated with Ivermectin. Our experience suggest that ivermectin could be a gold standard treatment in long COVID neurological symptoms . Further studies are needed to confirm this data.